| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |